Risks and limits of Menopause Senioren

Menopause is a natural biological transition, not a disease. However, risks increase in senior years: bone loss (osteoporosis), cardiovascular changes, and metabolic shifts due to estrogen decline. The limits of consumer DNA or lab tests are significant. Genetic markers (e.g., THY1) have no proven role in predicting menopause timing or complications. Food IgG tests are not medically validated and may lead to unnecessary dietary restrictions. MyBody-X tests are educational, not diagnostic. Women should rely on clinical assessments: DXA scans for bone density, lipid panels, and blood pressure monitoring. Hormone therapy requires professional guidance. The main risk of self-testing is misinterpretation and false reassurance or alarm. Evidence for genetic testing in menopause management is weak or absent. Safety note: Do not alter medications or supplements based solely on consumer test results. Consult a healthcare provider for personalized advice.